Overview

Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Study to determine a single dose bioavailablity of PA32540 is similar to EC aspirin 325 mg with respect to salicylic acid.
Phase:
Phase 1
Details
Lead Sponsor:
POZEN
Treatments:
Aspirin
Omeprazole